Home » Topics » BioWorld Science

BioWorld Science
RSS

New NFE2-related factor 2 activators described by Sanofi

April 1, 2022

Galderma discovers JAK-1 inhibitors

April 1, 2022

Medshine Discovery divulges thyroid hormone receptor beta agonists

April 1, 2022

BLU-945 for treatment-resistant EGFR T790M mutation-driven lung cancer

April 1, 2022

Zelluna collaborates with Etcembly and Nextera to optimize pipeline TCRs

March 31, 2022

Deleting protein switches macrophages to reduced-fat diet

March 31, 2022

New cathepsin L inhibitors for the treatment of HCC

March 31, 2022

Eloxx expands ELX-02 development program to include Alport syndrome

March 31, 2022

SBT-272 shows behavioral and metabolic improvements in mouse model of Huntington's disease

March 31, 2022

VYN-201 demonstrates promise in anti-collagen antibody-induced mouse model of RA

March 31, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...